U.S., Jan. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07338097) titled 'Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema' on Jan. 03.
Brief Summary: Diabetic macular edema is a frequent complication of long-standing diabetes mellitus in which fluid leaks into the central part of the retina (macula), leading to reduced vision. This randomized controlled trial will be conducted at Combined Military Hospital, Multan, to compare two commonly used intravitreal anti vascular endothelial growth factor medicines, aflibercept and bevacizumab, in adults aged 30 to 60 years with type 1 or type 2 diabetes mellitus for at least 5 years, central macular thickness of at least 300 microm...